Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 20 studies | 44% ± 16% | |
| macrophage | 15 studies | 46% ± 19% | |
| microglial cell | 15 studies | 67% ± 15% | |
| mast cell | 12 studies | 51% ± 17% | |
| smooth muscle cell | 12 studies | 36% ± 11% | |
| oligodendrocyte | 11 studies | 28% ± 12% | |
| fibroblast | 10 studies | 36% ± 10% | |
| GABAergic neuron | 9 studies | 35% ± 10% | |
| pericyte | 9 studies | 37% ± 17% | |
| glutamatergic neuron | 8 studies | 38% ± 15% | |
| astrocyte | 8 studies | 34% ± 16% | |
| adipocyte | 8 studies | 32% ± 7% | |
| epithelial cell | 7 studies | 35% ± 18% | |
| dendritic cell | 7 studies | 45% ± 13% | |
| myeloid cell | 7 studies | 38% ± 15% | |
| endothelial cell of lymphatic vessel | 7 studies | 40% ± 11% | |
| interneuron | 6 studies | 41% ± 21% | |
| neuron | 6 studies | 53% ± 25% | |
| monocyte | 6 studies | 51% ± 13% | |
| mesothelial cell | 5 studies | 57% ± 21% | |
| ciliated cell | 5 studies | 38% ± 18% | |
| basal cell | 5 studies | 50% ± 20% | |
| club cell | 5 studies | 44% ± 19% | |
| type I pneumocyte | 5 studies | 24% ± 6% | |
| type II pneumocyte | 5 studies | 52% ± 7% | |
| granule cell | 4 studies | 70% ± 8% | |
| cardiac muscle cell | 4 studies | 20% ± 4% | |
| amacrine cell | 4 studies | 34% ± 14% | |
| retina horizontal cell | 4 studies | 31% ± 10% | |
| retinal cone cell | 4 studies | 68% ± 18% | |
| cholangiocyte | 3 studies | 45% ± 21% | |
| classical monocyte | 3 studies | 19% ± 2% | |
| conventional dendritic cell | 3 studies | 30% ± 9% | |
| GABAergic interneuron | 3 studies | 27% ± 8% | |
| GABAergic amacrine cell | 3 studies | 26% ± 5% | |
| glycinergic amacrine cell | 3 studies | 27% ± 7% | |
| retinal rod cell | 3 studies | 38% ± 32% | |
| endothelial cell of vascular tree | 3 studies | 39% ± 9% | |
| hepatocyte | 3 studies | 69% ± 17% | |
| alveolar macrophage | 3 studies | 43% ± 7% | |
| capillary endothelial cell | 3 studies | 30% ± 7% | |
| respiratory goblet cell | 3 studies | 52% ± 20% | |
| goblet cell | 3 studies | 41% ± 21% | |
| mucus secreting cell | 3 studies | 55% ± 14% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| prostate | 100% | 1365.68 | 245 / 245 | 100% | 21.65 | 502 / 502 |
| thymus | 100% | 841.00 | 651 / 653 | 100% | 13.76 | 602 / 605 |
| intestine | 100% | 952.87 | 962 / 966 | 98% | 8.23 | 518 / 527 |
| stomach | 100% | 834.47 | 359 / 359 | 96% | 8.20 | 275 / 286 |
| pancreas | 99% | 701.23 | 325 / 328 | 97% | 8.84 | 172 / 178 |
| ovary | 100% | 1953.17 | 180 / 180 | 95% | 9.34 | 408 / 430 |
| lung | 100% | 1252.74 | 576 / 578 | 95% | 7.35 | 1098 / 1155 |
| breast | 100% | 1178.04 | 458 / 459 | 95% | 9.51 | 1059 / 1118 |
| skin | 97% | 1865.08 | 1762 / 1809 | 96% | 15.71 | 454 / 472 |
| esophagus | 100% | 1094.13 | 1439 / 1445 | 94% | 8.09 | 172 / 183 |
| bladder | 100% | 1156.67 | 21 / 21 | 92% | 8.07 | 466 / 504 |
| adrenal gland | 100% | 934.83 | 258 / 258 | 90% | 10.29 | 206 / 230 |
| kidney | 100% | 605.21 | 89 / 89 | 89% | 7.32 | 805 / 901 |
| uterus | 100% | 2144.74 | 170 / 170 | 80% | 6.87 | 367 / 459 |
| liver | 91% | 431.58 | 205 / 226 | 66% | 3.07 | 269 / 406 |
| brain | 69% | 588.97 | 1833 / 2642 | 74% | 3.18 | 520 / 705 |
| eye | 0% | 0 | 0 / 0 | 100% | 20.59 | 80 / 80 |
| ureter | 0% | 0 | 0 / 0 | 100% | 9.76 | 1 / 1 |
| adipose | 100% | 1039.45 | 1202 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 1116.51 | 1330 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 797.82 | 240 / 241 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 82% | 6.76 | 37 / 45 |
| peripheral blood | 67% | 619.68 | 624 / 929 | 0% | 0 | 0 / 0 |
| heart | 66% | 235.04 | 569 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 52% | 5.01 | 15 / 29 |
| muscle | 41% | 132.93 | 326 / 803 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0007221 | Biological process | positive regulation of transcription of Notch receptor target |
| GO_0007219 | Biological process | Notch signaling pathway |
| GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
| GO_0016607 | Cellular component | nuclear speck |
| GO_0005654 | Cellular component | nucleoplasm |
| GO_0005634 | Cellular component | nucleus |
| GO_0003713 | Molecular function | transcription coactivator activity |
| GO_0005515 | Molecular function | protein binding |
| Gene name | MAML3 |
| Protein name | Mastermind-like protein 3 (Mam-3) Mastermind like transcriptional coactivator 3 |
| Synonyms | KIAA1816 |
| Description | FUNCTION: Acts as a transcriptional coactivator for NOTCH proteins. Has been shown to amplify NOTCH-induced transcription of HES1. . |
| Accessions | ENST00000502696.1 H0Y920 Q96JK9 ENST00000509479.6 |